CN101677553A - 苯并咪唑及其药物组合物 - Google Patents

苯并咪唑及其药物组合物 Download PDF

Info

Publication number
CN101677553A
CN101677553A CN200880021064A CN200880021064A CN101677553A CN 101677553 A CN101677553 A CN 101677553A CN 200880021064 A CN200880021064 A CN 200880021064A CN 200880021064 A CN200880021064 A CN 200880021064A CN 101677553 A CN101677553 A CN 101677553A
Authority
CN
China
Prior art keywords
aryl
ring
alkyl
expression
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880021064A
Other languages
English (en)
Chinese (zh)
Inventor
伊瓦奥·奥吉马
李昇烨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of CN101677553A publication Critical patent/CN101677553A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN200880021064A 2007-04-20 2008-04-21 苯并咪唑及其药物组合物 Pending CN101677553A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91298007P 2007-04-20 2007-04-20
US60/912,980 2007-04-20
PCT/US2008/005084 WO2008130669A1 (en) 2007-04-20 2008-04-21 Benzimidazoles and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
CN101677553A true CN101677553A (zh) 2010-03-24

Family

ID=39875833

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880021064A Pending CN101677553A (zh) 2007-04-20 2008-04-21 苯并咪唑及其药物组合物

Country Status (17)

Country Link
US (1) US8232410B2 (enExample)
EP (1) EP2154966B1 (enExample)
JP (1) JP5400032B2 (enExample)
CN (1) CN101677553A (enExample)
AU (1) AU2008242488B2 (enExample)
BR (1) BRPI0810244A2 (enExample)
CA (1) CA2684594C (enExample)
DK (1) DK2154966T3 (enExample)
EA (1) EA016726B1 (enExample)
ES (1) ES2434693T3 (enExample)
HR (1) HRP20131103T1 (enExample)
IN (1) IN2009KN03959A (enExample)
MX (1) MX2009011281A (enExample)
PL (1) PL2154966T3 (enExample)
PT (1) PT2154966E (enExample)
SI (1) SI2154966T1 (enExample)
WO (1) WO2008130669A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103333170A (zh) * 2013-06-14 2013-10-02 清华大学 苯并咪唑类化合物及其用途
CN104395288A (zh) * 2012-04-12 2015-03-04 乔治城大学 用于治疗尤文肉瘤家族肿瘤的方法和组合物
CN106061951A (zh) * 2013-11-22 2016-10-26 纽约州立大学研究基金会 苯并咪唑及其在结核病治疗中的用途

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
US20120108823A1 (en) 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
ES2548913T3 (es) 2009-09-11 2015-10-21 Probiodrug Ag Derivados heterocíclicos como inhibidores de glutaminil ciclasa
WO2013116823A1 (en) * 2012-02-02 2013-08-08 The Research Foundation Of State University Of New York Benzimidazoles and uses thereof
WO2013142326A1 (en) * 2012-03-23 2013-09-26 The Research Foundation Of State University Of New York 5-carbonylamino-/(sulfonamido-) substituted benz imidazoles and use thereof treatment of tuberculosis
CA2927148A1 (en) 2013-10-24 2015-04-30 Georgetown University Methods and compositions for treating cancer
WO2015138611A2 (en) 2014-03-11 2015-09-17 Colorado State University Research Foundation Methods for improved in vitro-in vivo efficacy determination
KR102582563B1 (ko) * 2014-06-20 2023-09-25 재단법인 한국파스퇴르연구소 항감염 화합물
MX388564B (es) 2014-10-09 2025-03-20 Oncternal Therapeutics Inc Compuestos de indolinona y usos de los mismos.
JP6864379B2 (ja) 2016-03-31 2021-04-28 オンターナル セラピューティック インコーポレイテッドＯｎｃｔｅｒｎａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． インドール類似体及びその使用
KR102282794B1 (ko) 2016-07-29 2021-07-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌리논 화합물의 용도
CN111303092B (zh) * 2020-04-07 2021-05-25 山东昌邑灶户盐化有限公司 2,4-二硝基-6-氯苯胺衍生物、合成方法及其应用
WO2023283425A1 (en) 2021-07-09 2023-01-12 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61170732A (ja) * 1985-01-25 1986-08-01 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
CN101065363B (zh) * 2004-09-30 2012-05-02 詹森药业有限公司 可用作选择性雄激素受体调节剂（sarms）的新苯并咪唑衍生物
CN101438288A (zh) * 2006-03-15 2009-05-20 Csir公司 谷氨酰胺合成酶的磷酰基转移酶活性的调节

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104395288A (zh) * 2012-04-12 2015-03-04 乔治城大学 用于治疗尤文肉瘤家族肿瘤的方法和组合物
CN104395288B (zh) * 2012-04-12 2016-12-14 乔治城大学 用于治疗尤文肉瘤家族肿瘤的方法和组合物
CN107011242A (zh) * 2012-04-12 2017-08-04 乔治城大学 用于治疗尤文肉瘤家族肿瘤的方法和组合物
CN107011242B (zh) * 2012-04-12 2020-08-07 乔治城大学 用于治疗尤文肉瘤家族肿瘤的方法和组合物
CN103333170A (zh) * 2013-06-14 2013-10-02 清华大学 苯并咪唑类化合物及其用途
CN103333170B (zh) * 2013-06-14 2016-08-10 清华大学 苯并咪唑类化合物及其用途
CN106061951A (zh) * 2013-11-22 2016-10-26 纽约州立大学研究基金会 苯并咪唑及其在结核病治疗中的用途

Also Published As

Publication number Publication date
HRP20131103T1 (hr) 2013-12-20
CA2684594C (en) 2015-10-06
EP2154966B1 (en) 2013-08-21
US20100256203A1 (en) 2010-10-07
CA2684594A1 (en) 2008-10-30
PT2154966E (pt) 2013-11-13
AU2008242488A1 (en) 2008-10-30
AU2008242488B2 (en) 2014-10-30
SI2154966T1 (sl) 2014-02-28
ES2434693T3 (es) 2013-12-17
IN2009KN03959A (enExample) 2015-08-28
EP2154966A4 (en) 2010-12-15
EA016726B1 (ru) 2012-07-30
PL2154966T3 (pl) 2014-03-31
BRPI0810244A2 (pt) 2014-09-30
US8232410B2 (en) 2012-07-31
DK2154966T3 (da) 2013-11-18
MX2009011281A (es) 2010-03-08
EA200901423A1 (ru) 2010-06-30
WO2008130669A1 (en) 2008-10-30
JP2010524947A (ja) 2010-07-22
JP5400032B2 (ja) 2014-01-29
EP2154966A1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
CN101677553A (zh) 苯并咪唑及其药物组合物
EP1438310B1 (en) Beta-carbolin derivatives as ptp-inhibitors
CA2658506C (en) Acrylamide derivatives as fab 1 inhibitors
CN101528711A (zh) 可用作抗细菌剂的乙内酰脲衍生物
TWI393708B (zh) 異羥肟酸脂化合物，其用途及其之合成方法
EP0419210A1 (en) Novel benzimidazole compounds and their use
EP3585772B1 (en) 1, 4, 6-trisubstituted-2-alkyl-1h-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
HUP0104280A2 (hu) Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények
TW200927729A (en) 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
EA038317B1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
JP2007527904A (ja) グリコーゲンホスホリラーゼ阻害剤としてのピロロピリジン−２−カルボン酸ヒドラジド化合物
CN115232126B (zh) 一种β-卡波林-1,2,3-三唑化合物及其制备方法与抗阿尔兹海默病的应用
CN100546980C (zh) 苯并咪唑衍生物:制备方法及医药应用
EP2953947A1 (fr) 3,5-diaryl-azaindoles comme inhibiteurs de la protéine dyrk1a pour le traitement des déficiences cognitives liées au syndrome de down et à la maladie d'alzheimer
CN101287712B (zh) 杂环化合物
CN117903128A (zh) 一类ask1/pdk1双靶向抑制剂及其制备方法和应用
HK1141948A (en) Benzimidazoles and pharmaceutical compositions thereof
CN106496132B (zh) N-(4-取代苯基)-2-取代乙酰胺类化合物及其作为sirt2蛋白抑制剂的用途
CN111344284A (zh) 用作异戊二烯半胱氨酸羧甲基转移酶抑制剂的化合物
EP2323991B1 (en) Chymase inhibitors
WO2022244821A1 (ja) 抗ウイルス活性等の生理活性を有する化合物
JP2008208103A (ja) 新規な４−シクロへキシルジヒドロピリミジン−２−オン誘導体及びこれを含有するｓｔａｔ６活性化阻害剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1141948

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100324

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1141948

Country of ref document: HK